-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, in a research report published in the international journal eLife, scientists from the University of Queensland and other institutions found through research that asthma may increase the body's risk of influenza and cause dangerous mutations.
In this study, researchers conducted studies on animals and found that a non-allergic asthma called oligocellular asthma (PGA, paucigranulocytic asthma) may promote the proliferation of influenza viruses in the patient’s body.
The results of the researchers showed that PGA may inhibit the body's immune response to influenza, thereby causing the immune system to "give in" so that the influenza virus will be out of control and replicate faster than in healthy people.
These tests are currently only preliminary studies and are carried out in animal bodies.
This study provides the first evidence that asthma may affect the evolution of influenza virus and its transmission efficiency, which may cause more pathogenic strains to enter the community to infect people.
Original source:
Katina D Hulme, Anjana C Karawita, Cassandra Pegg, et al.